Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial.

Nordanstig J, James S, Andersson M, Andersson M, Delle M, Engström J, Fransson T, Gillgren P, Hilbertson A, Hörer TM, Jacobsson E, Kragsterman B, Lindbäck J, Lindgren H, Ludwigs K, Mellander S, Nelzén O, Olin R, Sigvant B, Skoog P, Starck J, Tegler G, Thorbjørnsen K, Truedson M, Wahlgren CM, Wallinder J, Öjersjö A, Falkenberg M, SWEDEPAD trial investigators

Open source

DOI
10.1016/s0140-6736(25)01584-3
Published
2025 Sep 13
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-01584-3,
  title = {Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial.},
  author = {Nordanstig J and James S and Andersson M and Andersson M and Delle M and Engström J and Fransson T and Gillgren P and Hilbertson A and Hörer TM and Jacobsson E and Kragsterman B and Lindbäck J and Lindgren H and Ludwigs K and Mellander S and Nelzén O and Olin R and Sigvant B and Skoog P and Starck J and Tegler G and Thorbjørnsen K and Truedson M and Wahlgren CM and Wallinder J and Öjersjö A and Falkenberg M and SWEDEPAD trial investigators},
  year = {2025},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)01584-3},
  url = {https://doi.org/10.1016/s0140-6736(25)01584-3}
}

RIS

TY  - JOUR
TI  - Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial.
AU  - Nordanstig J
AU  - James S
AU  - Andersson M
AU  - Andersson M
AU  - Delle M
AU  - Engström J
AU  - Fransson T
AU  - Gillgren P
AU  - Hilbertson A
AU  - Hörer TM
AU  - Jacobsson E
AU  - Kragsterman B
AU  - Lindbäck J
AU  - Lindgren H
AU  - Ludwigs K
AU  - Mellander S
AU  - Nelzén O
AU  - Olin R
AU  - Sigvant B
AU  - Skoog P
AU  - Starck J
AU  - Tegler G
AU  - Thorbjørnsen K
AU  - Truedson M
AU  - Wahlgren CM
AU  - Wallinder J
AU  - Öjersjö A
AU  - Falkenberg M
AU  - SWEDEPAD trial investigators
PY  - 2025
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)01584-3
UR  - https://doi.org/10.1016/s0140-6736(25)01584-3
ER  - 

APA

J, N., S, J., M, A., M, A., M, D., J, E., T, F., P, G., A, H., TM, H., E, J., B, K., J, L., H, L., K, L., S, M., O, N., R, O., B, S., P, S., J, S., G, T., K, T., M, T., CM, W., J, W., A, Ö., M, F., & investigators, S. T. (2025). Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)01584-3

Source records